So, this time we transcribed the information below the hard-to-read charts for your reading ease!

CM, acoramidis reduced the annual frequency of CVH due to AF/AFL by 43% compared to placebo and reduced the incidence ...

He is on the Board of Directors at SINTX Technologies, Inc., Puma Biotechnology, Inc. and BioCardia, Inc. Mr. Moyes was previously employed as a Chief Financial Officer & Treasurer by Sera Prognostics ...

Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has ...

ACMG Meeting, experts gathered to share breakthroughs in genetics. BioLogic Pharma Solutions stood out with new insights on ...